Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan;100(1):81-82.
doi: 10.4269/ajtmh.17-1022.

Use of Real-Time Polymerase Chain Reaction to Differentiate between Pathogenic Entamoeba histolytica and the Nonpathogenic Entamoeba dispar in Ecuador

Affiliations

Use of Real-Time Polymerase Chain Reaction to Differentiate between Pathogenic Entamoeba histolytica and the Nonpathogenic Entamoeba dispar in Ecuador

Ángel Guevara et al. Am J Trop Med Hyg. 2019 Jan.

Abstract

Microscopic examination of stool samples has been considered to be the "gold standard" for diagnosis of intestinal parasites. Recently, polymerase chain reaction (PCR) has been approved by the World Health Organization as the method of choice for the diagnosis of Entamoeba histolytica. Of the 106 stool samples collected from the Esmeraldas and Pichincha provinces of Ecuador, all (100%) were positive for E. histolytica/Entamoeba dispar by light microscopy, whereas using real-time PCR (RT-PCR) DNA amplification, 74 (69.8%) were positive for E. dispar and only three (2.8%) were positive for E. histolytica. Some 29 (27.4%) samples were negative for the presence of either E. histolytica or E. dispar, this may be due the presence of Entamoeba mosksvskii, which is morphologically identical to E. histolytica/E. dispar and not specifically targeted by the RT-PCR used. These results indicate the necessity of reevaluating the epidemiology of amebiasis in Ecuador as the prominent species found are nonpathogenic.

PubMed Disclaimer

References

    1. Stanley SL, Jr., 2003. Amoebiasis. Lancet 361: 1025–1034. - PubMed
    1. Fotedar R, Stark D, Beebe N, Marriott D, Ellis J, Harkness J, 2007. Laboratory diagnostic techniques for Entamoeba species. Clin Microbiol Rev 20: 511–532. - PMC - PubMed
    1. Jackson TF, 1998. Entamoeba histolytica and Entamoeba dispar are distinct species; clinical, epidemiological and serological evidence. Int J Parasitol 28: 181–186. - PubMed
    1. Oliveira FM, Neumann E, Gomes MA, Caliari MV, 2015. Entamoeba dispar: could it be pathogenic. Trop Parasitol 5: 9–14. - PMC - PubMed
    1. Formenti F, Perandin F, Bonafini S, Degani M, Bisoffi Z, 2015. Evaluation of the new ImmunoCard STAT!® CGE test for the diagnosis of amebiasis [in French]. Bull Soc Pathol Exot 108: 171–174. - PubMed

MeSH terms

LinkOut - more resources